CLX stock forecast, quote, news & analysis

Key Takeaways

• Clorox (CLX) shares fell roughly 19.6% over the last 30 days, declining from a closing price of $104.23 to $83.80.
• The selloff followed fiscal fourth-quarter results that showed a 42% year-over-year drop in adjusted EPS and a 13% organic sales decline.
• Analyst price-target cuts, a voluntary product recall, and a weaker consumer staples backdrop compounded the downward pressure.
• Over the last quarter, the stock has declined about 12% after rallying to a mid-August peak near $108.
• A steady $1.25-per-share quarterly dividend and the GOJO (Purell) acquisition remain supportive factors for the investment thesis.

Clorox (CLX) Company Overview and Market Position

The Clorox Company is a multinational manufacturer and marketer of consumer and professional products. Headquartered in Oakland, California, the company's portfolio spans cleaning and disinfecting products under the Clorox and Pine-Sol brands, household items such as Glad bags and wraps, Fresh Step cat litter, and Kingsford grilling products, as well as food brands including Hidden Valley Ranch and Brita water filtration. The company also owns natural personal care brands like Burt's Bees.

Clorox operates through retail, club, e-commerce, and professional channels across multiple countries. In April 2026, the company completed its acquisition of GOJO Industries, adding the Purell brand and professional hygiene solutions to its Health and Wellness segment. As a large-cap consumer staples company with a long track record of consistent dividend payments, Clorox is closely followed by income-oriented investors and those seeking defensive exposure to the household products industry.

Clorox (CLX) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, Clorox shares moved from a closing price of $104.23 to $83.80, a decline of approximately 19.6%. During this stretch, the stock reached a recent closing low of $81.80 before rebounding modestly to close at $83.80, up 2.4% in the latest session reflected in available data.

The longer three-month picture tells a similar but more nuanced story. From roughly $95 in late June, shares climbed to a mid-August closing peak near $108 before reversing sharply. Measured from late June to late September, the stock has declined about 12%, meaning a meaningful portion of the damage occurred during the most recent four-week window. The broader trend has been one of rising volatility, with a strong summer rally giving way to sustained selling pressure.

What Drove CLX Stock Price in the Last 30 Days

The sharp 30-day decline was driven by a combination of fundamental and sentiment factors. On August 3, Clorox reported mixed fiscal fourth-quarter 2026 results. While adjusted EPS of $1.66 and net sales of $1.95 billion narrowly beat consensus estimates, both figures declined year over year, with adjusted EPS down 42% and organic sales down 13%. Gross margin contracted by 520 basis points to 41.3%, pressured by higher commodity, manufacturing, and logistics costs.

Investors also reacted to the company's fiscal 2027 outlook, which called for gross margin of about 42% and flagged more than $200 million in expected inflation, front-loaded in the first half of the year. Management's cautious commentary around a challenging consumer and cost environment weighed on sentiment.

Selling pressure was amplified by analyst actions. In mid-September, Citi lowered its price target to $97 from $100 while maintaining a Neutral rating, Wells Fargo trimmed its target, and UBS reiterated a Neutral stance, noting that near-term operating conditions remain difficult. A voluntary product recall affecting roughly 6.3 million units, announced in mid-September over a bacterial contamination risk, added to the negative headlines. Broader weakness across the consumer staples sector contributed as well.

What Drove CLX Stock Performance Over the Last Quarter

Over the past quarter, Clorox's performance has been shaped by the tail end of its five-year digital transformation and the integration of GOJO Industries. The completion of the U.S. ERP implementation marked a milestone, but the associated inventory drawdown created difficult year-over-year comparisons that weighed on shipments and revenue growth throughout fiscal 2026.

The stock rallied into mid-August as investors focused on the GOJO acquisition, which has been accretive to adjusted EPS, and on a dividend increase to $1.25 per share announced in late July. That optimism faded as inflation expectations rose, promotional activity increased, and category weakness in areas such as cat litter and grilling persisted. The combination of mixed segment results and a cautious outlook ultimately reversed the summer gains, leaving shares well below their August peak.

Trending AI Robots

For traders looking to complement their own analysis with systematic, data-driven signals, Tickeron's Trending AI Robots page offers a curated view of the platform's AI-powered trading bots. Tickeron provides hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this section, helping users cut through the noise. Each bot differs in strategy, timeframe, and performance metrics, so investors can explore approaches that align with their own objectives and risk tolerance. Browsing the section is a straightforward way to see which automated strategies are currently generating interest among the community.

CLX Stock Forecast Drivers: What Investors Should Watch Next

Looking ahead, the most important factors for Clorox investors to monitor include the pace of organic sales recovery, the trajectory of commodity and logistics costs, and the company's progress integrating GOJO and capturing planned synergies. Management has guided to organic sales growth of 3.5% to 4.5% for fiscal 2027, with adjusted EPS expected in a range of $5.70 to $6.00, but the outlook assumes continued softness in category growth and elevated promotional intensity.

Investors should also track the ERP optimization benefits expected to build through the back half of the fiscal year, share trends in the household and lifestyle segments, and any further developments around the product recall. Macroeconomic variables, including commodity prices and consumer value-seeking behavior, remain key risks. As always, this is not financial advice, and individual circumstances should be considered before making investment decisions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations